D Nagore1, N Rapún2, I Antón2, J Harper3, A Martínez4. Show Affiliations » 1. R&D Department, Progenika Biopharma-Grifols, Derio, Spain. Electronic address: daniel.nagore@progenika.grifols.com. 2. Product Development and Support, Progenika Biopharma, Derio, Spain. 3. Australia National Applications, Grifols Australia Ltd, Melbourne, Vic, Australia. 4. R&D Department, Progenika Biopharma-Grifols, Derio, Spain.
Abstract
Mesh: See more » Enzyme-Linked Immunosorbent AssayHumansInfliximabReagent Kits, Diagnostic
Substances: See more » Reagent Kits, DiagnosticInfliximab
Year: 2017 PMID: 28274669 DOI: 10.1016/j.pathol.2017.01.004
Source DB: PubMed Journal: Pathology ISSN: 0031-3025 Impact factor: 5.306